Interaction of the neurotoxic and nontoxic secretory phospholipases A2 with the crotoxin inhibitor from Crotalus serum.
Crotalus durissus terrificus snakes possess a protein in their blood, named crotoxin inhibitor from Crotalus serum (CICS), which protects them against crotoxin, the main toxin of their venom. CICS neutralizes the lethal potency of crotoxin and inhibits its phospholipase A2 (PLA2) activity. The aim of the present study is to investigate the specificity of CICS towards snake venom neurotoxic PLA2s (beta-neurotoxins) and nontoxic mammalian PLA2s. This investigation shows that CICS does not affect the enzymatic activity of pancreatic and nonpancreatic PLA2s, bee venom PLA2 and Elapidae beta-neurotoxins but strongly inhibits the PLA2 activity of Viperidae beta-neurotoxins. Surface plasmon resonance and PAGE studies further demonstrated that CICS makes complexes with monomeric and multimeric Viperidae beta-neurotoxins but does not interact with nontoxic PLA2s. In the case of dimeric beta-neurotoxins from Viperidae venoms (crotoxin, Mojave toxin and CbICbII), which are made by the noncovalent association of a PLA2 with a nonenzymatic subunit, CICS does not react with the noncatalytic subunit, instead it binds tightly to the PLA2 subunit and induces the dissociation of the heterocomplex. In vitro assays performed with Torpedo synaptosomes showed a protective action of CICS against Viperidae beta-neurotoxins but not against other PLA2 neurotoxins, on primary and evoked liberation of acetylcholine. In conclusion, CICS is a specific PLA2 inhibitor of the beta-neurotoxins from the Viperidae family.
Faure
G
G
Unité des Venins, Institut Pasteur, Paris, France. fgrazyna@pasteur.fr
Villela
C
C
Perales
J
J
Bon
C
C
D000109:Acetylcholine / Q000378:metabolism; D000818:Animals; D002122:Calcium Chloride / Q000494:pharmacology; D003435:Crotalid Venoms / Q000737:chemistry; D017839:Crotalus / Q000097:blood*; D003439:Crotoxin / Q000633:toxicity; D004305:Dose-Response Relationship, Drug; D004546:Elapid Venoms / Q000633:toxicity; D004591:Electrophoresis, Polyacrylamide Gel; D004594:Electrophysiology; D006023:Glycoproteins / Q000378:metabolism* / Q000633:toxicity; D007700:Kinetics; D009498:Neurotoxins / Q000737:chemistry / Q000633:toxicity; D010741:Phospholipases A / Q000037:antagonists & inhibitors / Q000378:metabolism*; D054467:Phospholipases A2; D011189:Potassium Chloride / Q000494:pharmacology; D030162:Reptilian Proteins; D020349:Surface Plasmon Resonance; D014101:Torpedo; D014757:Viper Venoms / Q000633:toxicity
D003435:Crotalid Venoms; D004546:Elapid Venoms; D006023:Glycoproteins; D009498:Neurotoxins; D030162:Reptilian Proteins; D014757:Viper Venoms; C087438:phospholipase A2 inhibitor protein, Crotalus; C005082:notexin; C015523:taipoxin; D011189:Potassium Chloride; D003439:Crotoxin; C068117:ammodytoxin A; D010741:Phospholipases A; D054467:Phospholipases A2; D002122:Calcium Chloride; D000109:Acetylcholine